Skip to main content
. 2024 Jun 12;10:e53354. doi: 10.2196/53354

Figure 2.

Figure 2

Overall survival of (A) 716 patients with metachronous second primary lung cancer (MSPLC) after 2004 in different treatment groups before propensity score matching (PSM); (B) patients who received radiotherapy or no treatment, after PSM; (C) patients who received radiotherapy or underwent wedge resection, after PSM; (D) patients who received radiotherapy or underwent lobectomy, after PSM.